{
    "studyId": "ed021bf5-c2db-4dbc-adbe-1e5fb6c621c6",
    "studyTitle": "Study of Stage III Biliary Duct Cancer",
    "studyDesigns": [
        {
            "studyDesignId": "SD01",
            "studyDesignName": "Design for Stage III",
            "studyDesignDescription": "Stage III Biliary Duct Cancer",
            "studyWorkflows": [
                {
                    "workFlowId": "Timeline01",
                    "workflowDescription": "Timeline for Stage III",
                    "workFlowSoA": {
                        "orderOfActivities": [
                            "Informed consent",
                            "Eligibility criteria",
                            "Demography",
                            "Medical history",
                            "Disease characteristics",
                            "Physical exam",
                            "Height",
                            "12-lead ECG",
                            "Hematology (predose)",
                            "Chemistry (predose)",
                            "Serology",
                            "Urinalysis",
                            "Pregnancy test",
                            "Ensure availability of medication X",
                            "Hospitalization",
                            "Weight",
                            "Vital signs",
                            "adverse events",
                            "Concomitant medications"
                        ],
                        "SoA": [
                            {
                                "encounterName": "SCREENING VISIT (Day 1)",
                                "activities": [
                                    "Informed consent",
                                    "Eligibility criteria",
                                    "Demography",
                                    "Disease characteristics",
                                    "12-lead ECG",
                                    "Hematology (predose)",
                                    "Serology",
                                    "adverse events"
                                ]
                            },
                            {
                                "encounterName": "RUN-IN VISIT 1 (Day 15)",
                                "activities": [
                                    "Demography",
                                    "Eligibility criteria"
                                ]
                            },
                            {
                                "encounterName": "RUN-IN VISIT 2 (Day 1)",
                                "activities": [
                                    "Disease characteristics",
                                    "Physical exam"
                                ]
                            },
                            {
                                "encounterName": "RUN-IN VISIT 3 (Day 15)",
                                "activities": [
                                    "Physical exam",
                                    "Height"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 1, TREATMENT 1 (Day 1)",
                                "activities": [
                                    "12-lead ECG",
                                    "Hematology (predose)"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 1, TREATMENT 2 (Day 10)",
                                "activities": [
                                    "Chemistry (predose)",
                                    "Serology"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 1, TREATMENT 3 (Day 18)",
                                "activities": [
                                    "Urinalysis",
                                    "Pregnancy test"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 2, TREATMENT 1 (Day 20)",
                                "activities": [
                                    "Pregnancy test",
                                    "Ensure availability of medication X"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 2, TREATMENT 2 (Day 23)",
                                "activities": [
                                    "Hospitalization",
                                    "Weight"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 3, TREATMENT 1 (Day 25)",
                                "activities": [
                                    "Vital signs",
                                    "adverse events"
                                ]
                            },
                            {
                                "encounterName": "CYCLE 3, TREATMENT 2 (Day 30)",
                                "activities": [
                                    "adverse events",
                                    "Concomitant medications"
                                ]
                            },
                            {
                                "encounterName": "FU 1 (WEEK 6)",
                                "activities": [
                                    "Concomitant medications",
                                    "Eligibility criteria"
                                ]
                            },
                            {
                                "encounterName": "FU 2 (MONTH 1)",
                                "activities": [
                                    "Demography",
                                    "Informed consent",
                                    "Disease characteristics",
                                    "Eligibility criteria"
                                ]
                            }
                        ]
                    }
                }
            ]
        }
    ]
}